The upregulation of IL-6 and TNF-α in patients with CAD is associated with hypomethylation of the IL-6 and TNF-α genes, which could serve as a potential biomarker for predicting early-onset CAD risk [40]. This evidence concerns the gene IL6 and coronary artery disorder.